Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection

被引：17
|
作者：
Doi, Akira [1 ]
Hikita, Hayato [1 ]
Sakamori, Ryotaro [1 ]
Tahata, Yuki [1 ]
Kai, Yugo [1 ]
Yamada, Ryoko [1 ]
Yakushijin, Takayuki [2 ]
Mita, Eiji [3 ]
Ohkawa, Kazuyoshi [4 ]
Imai, Yasuharu [5 ]
Furuta, Kunimaro [1 ]
Kodama, Takahiro [1 ]
Tatsumi, Tomohide [1 ]
Takehara, Tetsuo [1 ]
机构：
[1] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Osaka Gen Med Ctr, Dept Gastroenterol & Hepatol, Osaka, Japan
[3] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Japan
[4] Osaka Int Canc Inst, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan
[5] Ikeda Municipal Hosp, Ikeda, Osaka, Japan
来源：
HEPATOLOGY | 2018年 / 68卷 / 01期
关键词：
D O I：
10.1002/hep.29836
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：380 / 383
页数：4
相关论文
共 50 条
  • [41] Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
    Ashley N. Brown
    Lin Liu
    Jaime L. Rodriquez
    Lisa Zhao
    Layla Schuster
    Eric Li
    Gary P. Wang
    Michael N. Neely
    Walter Yamada
    George L. Drusano
    Scientific Reports, 7
  • [42] Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir
    Manabe, Takushi
    Tadokoro, Tomoko
    Nakahara, Mai
    Ohura, Kyoko
    Fujita, Koji
    Tani, Joji
    Morishita, Asahiro
    Ogawa, Chikara
    Masaki, Tsutomu
    INTERNAL MEDICINE, 2023, 62 (17) : 2507 - 2511
  • [43] Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors
    Smith, David
    Magri, Andrea
    Bonsall, David
    Ip, Camilla L. C.
    Trebes, Amy
    Brown, Anthony
    Piazza, Palo
    Bowden, Rory
    Dung Nguyen
    Ansari, M. Azim
    Simmonds, Peter
    Barnes, Eleanor
    HEPATOLOGY, 2019, 69 (05) : 1861 - 1872
  • [44] Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection
    Ito, Jun
    Suda, Goki
    Yamamoto, Yoshiya
    Nagasaka, Atsushi
    Furuya, Ken
    Kumagai, Kenichi
    Kikuchi, Hideaki
    Miyagishima, Takuto
    Kobayashi, Tomoe
    Kimura, Megumi
    Yamasaki, Kazushi
    Umemura, Machiko
    Izumi, Takaaki
    Tsunematsu, Seiji
    Sato, Fumiyuki
    Tsukuda, Yoko
    Terashita, Katsumi
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    HEPATOLOGY RESEARCH, 2016, 46 (13) : 1294 - 1303
  • [45] Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
    Nam, Hee Chul
    Lee, Hae Lim
    Yang, Hyun
    Song, Myeong Jun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (02) : 259 - 266
  • [46] Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection
    Miura, Mika
    Maekawa, Shinya
    Sato, Mitsuaki
    Komatsu, Nobutoshi
    Tatsumi, Akihisa
    Takano, Shinichi
    Amemiya, Fumitake
    Nakayama, Yasuhiro
    Inoue, Taisuke
    Sakamoto, Minoru
    Enomoto, Nobuyuki
    HEPATOLOGY RESEARCH, 2014, 44 (14) : E360 - E367
  • [47] Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection
    Einsiedel, Hagen Graf
    Christiansen, Holger
    Wiegand, Johannes
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (12) : 1373 - 1373
  • [48] Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis
    Lim, Joseph K.
    Liapakis, Ann Marie
    Shiffman, Mitchell L.
    Lok, Anna S.
    Zeuzem, Stefan
    Terrault, Norah A.
    Park, James S.
    Landis, Charles S.
    Hassan, Mohamed
    Gallant, Joel
    Kuo, Alexander
    Pockros, Paul J.
    Vainorius, Monika
    Akushevich, Lucy
    Michael, Larry
    Fried, Michael W.
    Nelson, David R.
    Ben-Ari, Ziv
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (11) : 1811 - +
  • [49] The Safety and Effectiveness of Ledipasvir-Sofosbuvir in Adolescents 12-17 Years Old With Hepatitis C Virus Genotype 1 Infection
    Balistreri, William F.
    Murray, Karen F.
    Rosenthal, Philip
    Bansal, Sanjay
    Lin, Chuan-Hao
    Kersey, Kathryn
    Massetto, Benedetta
    Zhu, Yanni
    Kanwar, Bittoo
    German, Polina
    Svarovskaia, Evguenia
    Brainard, Diana M.
    Wen, Jessica
    Gonzalez-Peralta, Regino P.
    Jonas, Maureen M.
    Schwarz, Kathleen
    HEPATOLOGY, 2017, 66 (02) : 371 - 378
  • [50] Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population
    Kouris, George
    Hydery, Tasmina
    Greenwood, Bonnie C.
    Lavitas, Pavel
    Price, Mylissa
    Clements, Karen
    Alper, Caroline J.
    Lenz, Kimberly
    Jeffrey, Paul L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 591 - +
12345